glp 1 agonists mechanism of action GLP-1 Receptor as Treatments for Type 2 Diabetes Frontiers | GLP−1 receptor agonists

Lilly's oral GLP-1, orforglipron, demonstrated meaningful weight loss and cardiometabolic improvements in complete ATTAIN-1 results published in The New England Journal of Medicine [press release]

Preparing for the Program Patients should take the following steps beginning July 1: 1

This trial was important because a significant clinical benefit was seen in a lower-risk patient population irrespective of baseline cardiovascular risk

In cases where an employer is providing plan coverage for GLP-1 medications for obesity, there are risks and potential unforeseen consequences if the coverage doesnt have a defined plan structure and a managed process for treatment

Obes Pillars 15:100186 Karakasis P, Patoulias D, Fragakis N, Mantzoros CS (2025) Effect of glucagon-like peptide-1 receptor agonists and co-agonists on body composition: systematic review and network meta-analysis